Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia

被引：0
|
作者：
Perz, JB [1 ]
Sanz, J [1 ]
Ghorashian, S [1 ]
Chaidos, A [1 ]
Kaeda, J [1 ]
Szydlo, RM [1 ]
Marin, DC [1 ]
Olavarria, E [1 ]
Apperley, JF [1 ]
机构：
[1] Hammersmith Hosp, London, England
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [1] Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia
    Perz, Jolanta B.
    Khorashad, Jamshid S.
    Marin, David
    Apperley, Jane F.
    Olavarria, Eduardo
    HAEMATOLOGICA, 2006, 91 (08) : 1145 - 1146
  • [2] Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era
    Pavlu, J.
    Auner, H.
    Szydlo, R.
    Olavarria, E.
    Giles, C.
    Klammer, M.
    Kew, A.
    Milojkovic, D.
    Gabriel, I.
    Rezvani, K.
    Dazzi, F.
    Marin, D.
    Goldman, J.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S49 - S49
  • [3] Imatinib mesylate for treatment of relapse after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia
    Arqueros, V
    Espigares, A
    Roman, J
    Martin, A
    Jimenez, A
    Fernandez, C
    Capote, M
    Molina, J
    Heiniger, A
    Torres, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S228 - S228
  • [4] Imatinib mesylate treatment of patients with chronic myeloid leukaemia relapsing following allogeneic stem cell transplantation
    Conneally, E
    Carroll, P
    Neat, M
    Haslam, K
    Gately, K
    Ryan, J
    Lawler, M
    McCann, S
    BLOOD, 2004, 104 (11) : 248B - 249B
  • [5] Allogeneic stem cell transplantation for advanced phase chronic myeloid leukaemia: experience from the imatinib era
    Holroyd, A.
    Pearce, R.
    Latif, A. L.
    Byrne, J.
    Roomallah, B.
    Clark, R. E.
    Marks, D. I.
    Shaw, B.
    Cook, G.
    Apperley, J. F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S126 - S126
  • [6] Allogeneic haemotopoietic stem cell transplantation outcomes in imatinib-treated chronic myeloid leukaemia patients
    Ahn, H. K.
    Jung, C. W.
    Kim, K.
    Jang, J. H.
    Kim, D. H.
    Yoon, S. S.
    Kim, I. H.
    Sohn, S. K.
    Moon, J. H.
    Lee, J. H.
    Lee, K. H.
    Won, J. H.
    Lee, N. S.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S244 - S244
  • [7] Imatinib mesylate for the treatment of relapse of chronic myeloid leukaemia after allogeneic stem cell transplantation.
    Olavarria, E
    Fischer, T
    Ottmann, O
    Clark, R
    Bandini, G
    Byrne, J
    Lipton, J
    Niederwieser, D
    Goldman, J
    BLOOD, 2002, 100 (11) : 329B - 329B
  • [8] Imatinib combined with allogeneic stem cell transplantation for chronic myeloid leukemia
    Luo, Yi
    Huang, He
    Tan, Yamin
    Han, Xiaoyan
    Zhu, Xiaoli
    Lai, Xiaoyu
    Zhen, Cai
    Lin, Maofang
    BLOOD, 2007, 110 (11) : 871A - 871A
  • [9] Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia
    Koldehoff, M
    Elmaagacli, AH
    Steckel, NK
    Hlinka, M
    Ditschkowski, M
    Trenschel, R
    Peceny, R
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [10] Imatinib therapy for chronic myeloid leukaemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    Martinelli, G
    Palandri, F
    Amabile, M
    Bonifazi, F
    Bandini, G
    Benedetti, F
    Usala, E
    Angelucci, E
    Tiribelli, M
    Fanin, R
    Sorio, M
    Arpinati, M
    Testoni, N
    Falcioni, S
    Giannini, M
    Poerio, A
    Soverini, S
    Pane, F
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
12345